212 related articles for article (PubMed ID: 19689365)
21. Melanocortins and their receptors and antagonists.
Voisey J; Carroll L; van Daal A
Curr Drug Targets; 2003 Oct; 4(7):586-97. PubMed ID: 14535656
[TBL] [Abstract][Full Text] [Related]
22. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
23. Effect of the melanocortin receptor stimulation or inhibition on ethanol intake in alcohol-preferring rats.
Polidori C; Geary N; Massi M
Peptides; 2006 Jan; 27(1):144-9. PubMed ID: 16198024
[TBL] [Abstract][Full Text] [Related]
24. Determination of the melanocortin-4 receptor structure identifies Ca
Yu J; Gimenez LE; Hernandez CC; Wu Y; Wein AH; Han GW; McClary K; Mittal SR; Burdsall K; Stauch B; Wu L; Stevens SN; Peisley A; Williams SY; Chen V; Millhauser GL; Zhao S; Cone RD; Stevens RC
Science; 2020 Apr; 368(6489):428-433. PubMed ID: 32327598
[TBL] [Abstract][Full Text] [Related]
25. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
26. Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μM MC4R Partial Agonist.
Fleming KA; Freeman KT; Powers MD; Santos RG; Debevec G; Giulianotti MA; Houghten RA; Doering SR; Pinilla C; Haskell-Luevano C
J Med Chem; 2019 Mar; 62(5):2738-2749. PubMed ID: 30741545
[TBL] [Abstract][Full Text] [Related]
27. Dynamic regulation of hypothalamic neuropeptide gene expression and food intake by melanocortin analogues and reversal with melanocortin-4 receptor antagonist.
Kim RY; Shin SW; Kim BJ; Lee W; Baik JH
Biochem Biophys Res Commun; 2005 Apr; 329(4):1178-85. PubMed ID: 15766551
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
[TBL] [Abstract][Full Text] [Related]
29. Modulation of γ2-MSH hepatoprotection by antisense peptides and melanocortin subtype 3 and 4 receptor antagonists.
Turcic P; Stambuk N; Konjevoda P; Kelava T; Gabricevic M; Stojkovic R; Aralica G
Med Chem; 2015; 11(3):286-95. PubMed ID: 25219927
[TBL] [Abstract][Full Text] [Related]
30. The melanocortin system and energy balance.
Butler AA
Peptides; 2006 Feb; 27(2):281-90. PubMed ID: 16434123
[TBL] [Abstract][Full Text] [Related]
31. Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions.
Haskell-Luevano C; Lim S; Yuan W; Cone RD; Hruby VJ
Peptides; 2000 Jan; 21(1):49-57. PubMed ID: 10704719
[TBL] [Abstract][Full Text] [Related]
32. Melanocortin potentiates leptin-induced STAT3 signaling via MAPK pathway.
Zhang Y; Wu X; He Y; Kastin AJ; Hsuchou H; Rosenblum CI; Pan W
J Neurochem; 2009 Jul; 110(1):390-9. PubMed ID: 19457101
[TBL] [Abstract][Full Text] [Related]
33. Melanocortin peptides affect the motivation to feed in rainbow trout (Oncorhynchus mykiss).
Schjolden J; Schiöth HB; Larhammar D; Winberg S; Larson ET
Gen Comp Endocrinol; 2009 Jan; 160(2):134-8. PubMed ID: 19027741
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.
Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C
Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274
[TBL] [Abstract][Full Text] [Related]
35. Constitutive activity of neural melanocortin receptors.
Tao YX; Huang H; Wang ZQ; Yang F; Williams JN; Nikiforovich GV
Methods Enzymol; 2010; 484():267-79. PubMed ID: 21036237
[TBL] [Abstract][Full Text] [Related]
36. 60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH.
Anderson EJ; Çakir I; Carrington SJ; Cone RD; Ghamari-Langroudi M; Gillyard T; Gimenez LE; Litt MJ
J Mol Endocrinol; 2016 May; 56(4):T157-74. PubMed ID: 26939593
[TBL] [Abstract][Full Text] [Related]
37. The role of melanocortin-3 and -4 receptor in regulating appetite, energy homeostasis and neuroendocrine function in the pig.
Barb CR; Robertson AS; Barrett JB; Kraeling RR; Houseknecht KL
J Endocrinol; 2004 Apr; 181(1):39-52. PubMed ID: 15072565
[TBL] [Abstract][Full Text] [Related]
38. Design of novel melanotropin agonists and antagonists with high potency and selectivity for human melanocortin receptors.
Cai M; Mayorov AV; Ying J; Stankova M; Trivedi D; Cabello C; Hruby VJ
Peptides; 2005 Aug; 26(8):1481-5. PubMed ID: 15876475
[TBL] [Abstract][Full Text] [Related]
39. Differential regulation of cAMP-mediated gene transcription and ligand selectivity by MC3R and MC4R melanocortin receptors.
Lee EJ; Lee SH; Jung JW; Lee W; Kim BJ; Park KW; Lim SK; Yoon CJ; Baik JH
Eur J Biochem; 2001 Feb; 268(3):582-91. PubMed ID: 11168397
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction.
Chen M; Aprahamian CJ; Celik A; Georgeson KE; Garvey WT; Harmon CM; Yang Y
Biochemistry; 2006 Jan; 45(4):1128-37. PubMed ID: 16430209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
